Three Biotech Startups Plan $400 Million U.S. IPOs Amid Sector Resurgence
Three healthcare startups are aiming to raise up to $400 million through their U.S. initial public offerings, highlighting a strong resurgence in the biotech sector after a two-year downturn. September...